Frailty predictors and outcomes among older patients with cardiovascular disease: Data from Fragicor

Alberto Frisoli1, Sheila Jean McNeill Ingham2, Ângela T Paes3

  • 1Cardiogeriatric Unit, Cardiology Division, Federal University of São Paulo, São Paulo, Brazil; Cardiology Division, Federal University of São Paulo, São Paulo, Brazil.

Insights

Older adults with cardiovascular disease (CVD) are more likely to be frail. Frailty predicts disability and increases mortality risk, highlighting the need for early diagnosis in this population.

Area of Science:

  • Gerontology
  • Cardiology
  • Public Health

Background:

  • Cardiovascular disease (CVD) is prevalent in older adults.
  • Frailty is a geriatric syndrome associated with adverse health outcomes.
  • Predictive factors and outcomes of frailty in CVD patients require further investigation.

Purpose of the Study:

  • To identify predictive factors for frailty in older outpatients with CVD.
  • To assess the predictive value of frailty for mortality, disability, and hospitalization at 1-year follow-up.

Main Methods:

  • Prospective cohort study of 172 outpatients aged over 65 with at least one CVD.
  • Frailty assessed using Fried's phenotype criteria (weight loss, exhaustion, weakness, slow walking, low physical activity).
  • Data collected on CVD, hemodynamic parameters (blood pressure, heart rate, ejection fraction), disability, and hospitalizations.

Main Results:

  • Prevalence of frailty was 39.8%, prefrail 51.5%, and robust 8.7%.
  • Myocardial infarction, multiple CVDs, and lower systolic and diastolic blood pressure were significant predictors of frailty.
  • Frailty independently predicted disability (OR: 3.94) and increased mortality risk threefold compared to robust individuals.

Conclusions:

  • Older outpatients with CVD exhibit a higher prevalence of frailty.
  • Low systolic and diastolic blood pressure are associated with frailty in this population.
  • Diagnosing frailty in CVD patients is crucial due to its strong association with mortality and disability.

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
339
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
746
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
934
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
368
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.3K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
329